vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Cherry Hill Mortgage Investment Corp (CHMI). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $11.8M, roughly 1.6× Cherry Hill Mortgage Investment Corp). On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -37.2%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -15.2%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.
APYX vs CHMI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $11.8M |
| Net Profit | $-1.3M | — |
| Gross Margin | 62.6% | 78.9% |
| Operating Margin | 0.1% | 72.1% |
| Net Margin | -6.8% | — |
| Revenue YoY | 34.7% | -37.2% |
| Net Profit YoY | 71.9% | — |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $11.8M | ||
| Q3 25 | $12.9M | $8.6M | ||
| Q2 25 | $11.4M | $6.0M | ||
| Q1 25 | $9.4M | $-3.0M | ||
| Q4 24 | $14.2M | $18.7M | ||
| Q3 24 | $11.5M | $-7.1M | ||
| Q2 24 | $12.1M | $6.6M | ||
| Q1 24 | $10.2M | $16.3M |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $4.5M | ||
| Q2 25 | $-3.8M | $1.6M | ||
| Q1 25 | $-4.2M | $-7.0M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | $-12.4M | ||
| Q2 24 | $-6.6M | $784.0K | ||
| Q1 24 | $-7.6M | $12.1M |
| Q4 25 | 62.6% | 78.9% | ||
| Q3 25 | 64.4% | 73.2% | ||
| Q2 25 | 62.3% | 67.7% | ||
| Q1 25 | 60.1% | 183.4% | ||
| Q4 24 | 63.0% | 83.3% | ||
| Q3 24 | 60.5% | 145.3% | ||
| Q2 24 | 61.7% | 47.5% | ||
| Q1 24 | 58.1% | 83.9% |
| Q4 25 | 0.1% | 72.1% | ||
| Q3 25 | -6.5% | 56.0% | ||
| Q2 25 | -22.6% | 44.4% | ||
| Q1 25 | -32.4% | 223.6% | ||
| Q4 24 | -21.4% | 76.2% | ||
| Q3 24 | -31.6% | 171.8% | ||
| Q2 24 | -45.7% | 22.0% | ||
| Q1 24 | -64.6% | 78.0% |
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | 52.7% | ||
| Q2 25 | -33.2% | 25.9% | ||
| Q1 25 | -44.0% | 229.2% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | 175.8% | ||
| Q2 24 | -54.0% | 11.9% | ||
| Q1 24 | -74.0% | 73.7% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.29 | ||
| Q4 24 | — | $0.30 | ||
| Q3 24 | — | $-0.49 | ||
| Q2 24 | $-0.19 | $-0.06 | ||
| Q1 24 | $-0.22 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $54.9M |
| Total DebtLower is stronger | $37.5M | $146.3M |
| Stockholders' EquityBook value | $14.5M | $236.0M |
| Total Assets | $66.8M | $1.5B |
| Debt / EquityLower = less leverage | 2.58× | 0.62× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $54.9M | ||
| Q3 25 | $25.1M | $55.4M | ||
| Q2 25 | $29.3M | $58.0M | ||
| Q1 25 | $31.0M | $47.3M | ||
| Q4 24 | $31.7M | $46.3M | ||
| Q3 24 | $28.0M | $50.2M | ||
| Q2 24 | $32.7M | $52.4M | ||
| Q1 24 | $37.3M | $47.5M |
| Q4 25 | $37.5M | $146.3M | ||
| Q3 25 | $37.5M | $148.0M | ||
| Q2 25 | $37.5M | $150.1M | ||
| Q1 25 | $37.5M | $150.1M | ||
| Q4 24 | $37.5M | $152.1M | ||
| Q3 24 | $37.5M | $151.8M | ||
| Q2 24 | — | $160.5M | ||
| Q1 24 | — | $167.5M |
| Q4 25 | $14.5M | $236.0M | ||
| Q3 25 | $5.8M | $233.1M | ||
| Q2 25 | $7.3M | $229.9M | ||
| Q1 25 | $10.5M | $226.6M | ||
| Q4 24 | $14.2M | $230.3M | ||
| Q3 24 | $11.0M | $236.7M | ||
| Q2 24 | $14.7M | $234.5M | ||
| Q1 24 | $20.3M | $247.0M |
| Q4 25 | $66.8M | $1.5B | ||
| Q3 25 | $57.4M | $1.5B | ||
| Q2 25 | $58.2M | $1.5B | ||
| Q1 25 | $60.2M | $1.4B | ||
| Q4 24 | $64.8M | $1.5B | ||
| Q3 24 | $60.7M | $1.6B | ||
| Q2 24 | $65.4M | $1.4B | ||
| Q1 24 | $70.7M | $1.4B |
| Q4 25 | 2.58× | 0.62× | ||
| Q3 25 | 6.41× | 0.63× | ||
| Q2 25 | 5.17× | 0.65× | ||
| Q1 25 | 3.57× | 0.66× | ||
| Q4 24 | 2.64× | 0.66× | ||
| Q3 24 | 3.40× | 0.64× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $19.1M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $19.1M | ||
| Q3 25 | $-3.5M | $-2.4M | ||
| Q2 25 | $-1.2M | $12.5M | ||
| Q1 25 | $-702.0K | $682.0K | ||
| Q4 24 | $-2.9M | $-4.7M | ||
| Q3 24 | $-4.4M | $4.4M | ||
| Q2 24 | $-4.3M | $4.1M | ||
| Q1 24 | $-6.3M | $-19.1M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.53× | ||
| Q2 25 | — | 7.98× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | — | -1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
